🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12572+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12572 recruiting trials

NARecruitingNCT07345585

Probiotics for Autism Spectrum Disorders: a Randomized Controlled Trial (The PASD Study)

🏥 Federico II University📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05989659

Transitioning to Home or In-center Dialysis

👨‍⚕️ Annie-Claire Nadeau-Fredette, MD, CIUSSS de l'Est-de-l'Ile-de-Montréal📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT06146738

The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)

👨‍⚕️ Jasper Gerritsen, MD PhD, Erasmus Medical Center📍 8 sites📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05837806

Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)

👨‍⚕️ Hailong Hu, MD,PhD, Tianjin Medical University Second Hospital📍 1 site📅 Started Dec 2022View details ↗
Phase 1RecruitingNCT05562024

TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma

👨‍⚕️ Qiang Zhao, Doctor, Tianjin Medical University Cancer Institute and Hospital📍 2 sites📅 Started Dec 2022View details ↗
Phase 1, PHASE2RecruitingNCT05673057

Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome

🏥 Molecular Partners AG📍 9 sites📅 Started Dec 2022View details ↗
RecruitingNCT05377307

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

👨‍⚕️ Chen-Lung Lin, MD, Pell Bio-Med Technology Co., Ltd.📍 5 sites📅 Started Dec 2022View details ↗
Phase 3RecruitingNCT05568719

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

👨‍⚕️ Pfizer CT.gov Call Center, Pfizer📍 16 sites📅 Started Dec 2022View details ↗
Phase 2RecruitingNCT05526989

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

👨‍⚕️ Juskaran Chadha, DO, Moffitt Cancer Center📍 2 sites📅 Started Dec 2022View details ↗
Phase 1, PHASE2RecruitingNCT05442515

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

👨‍⚕️ Nirali N Shah, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Dec 2022View details ↗
Phase 2, PHASE3Enrolling by InvitationNCT05396105

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

👨‍⚕️ Study Director, Pharvaris Netherlands B.V.📍 63 sites📅 Started Dec 2022View details ↗
NARecruitingNCT05689476

Electrical Activity of the Diaphragm and Respiratory Mechanics During NAVA

🏥 University of Padova📍 1 site📅 Started Dec 2022View details ↗
Phase 2RecruitingNCT03673748

Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells

👨‍⚕️ Julia Barbado, MD, PhD, University Hospital Río Hortega, Valladolid, Spain📍 1 site📅 Started Dec 2022View details ↗
RecruitingNCT05917106

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

🏥 Jinling Hospital, China📍 1 site📅 Started Dec 2022View details ↗
Phase 3RecruitingNCT05645107

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

🏥 Grifols Therapeutics LLC📍 61 sites📅 Started Dec 2022View details ↗
Phase 1RecruitingNCT04953910

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

🏥 Taiho Oncology, Inc.📍 22 sites📅 Started Dec 2022View details ↗
Phase 2RecruitingNCT05512351

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma

👨‍⚕️ Xingyao Bu, Henan Provincial People's Hospital📍 1 site📅 Started Dec 2022View details ↗
NARecruitingNCT05419960

Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta

👨‍⚕️ Natalie Loundon, MD, PhD, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Dec 2022View details ↗
Phase 1RecruitingNCT05412290

Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma

👨‍⚕️ Armin Ghobadi, M.D., Washington University School of Medicine📍 1 site📅 Started Dec 2022View details ↗
RecruitingNCT07450846

Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome

🏥 Bicetre Hospital📍 1 site📅 Started Dec 2022View details ↗
← PreviousPage 439 of 629Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →